Data from the ACRIN 6685 Trial HNSCC-FDG-PET/CT

ACRIN-HNSCC-FDG-PET/CT (ACRIN 6685) is a Multicenter Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head and Neck Cancer Patients. The objective of this study was to determine the negative predictive value (NPV) of positron emission tomography (PET)/computed tomography CT for clinically N0 neck based upon pathologic sampling of the neck lymph nodes and to determine PET/CT’s potential to change treatment of the N0 neck.

ACRIN-HNSCC-FDG-PET/CT（ACRIN 6685）是一项针对头颈部癌FDG-PET/CT分期及其对头颈部癌患者N0颈部外科治疗影响的多中心试验。本研究的目标为，基于颈部淋巴结的病理学取样结果，明确针对临床N0颈部的正电子发射断层显像（positron emission tomography, PET）/计算机断层扫描（computed tomography, CT）的阴性预测值（negative predictive value, NPV），并确定PET/CT改变N0颈部治疗方案的潜在能力。

搜集汇总

背景与挑战

背景概述

该数据集来自ACRIN 6685多中心试验，专注于头颈癌患者的FDG-PET/CT影像数据，旨在评估PET/CT在临床N0颈部淋巴结中的阴性预测价值，并研究其对治疗决策的影响。数据集特点包括多中心采集和针对头颈癌的影像与病理对照分析。